Glycogen Storage Disease Clinical Trials

20 recruitingLast updated: June 18, 2026

There are 20 actively recruiting glycogen storage disease clinical trials across 46 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4. Top locations include Durham, North Carolina, United States, Salt Lake City, Utah, United States, Orange, California, United States. Updated daily from ClinicalTrials.gov.


Glycogen Storage Disease Trials at a Glance

20 actively recruiting trials for glycogen storage disease are listed on ClinicalTrialsFinder across 6 cities in 46 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Durham, Salt Lake City, and Orange. Lead sponsors running glycogen storage disease studies include Genzyme, a Sanofi Company, Duke University, and Connecticut Children's Medical Center.

Browse glycogen storage disease trials by phase

Treatments under study

About Glycogen Storage Disease Clinical Trials

Looking for clinical trials for Glycogen Storage Disease? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glycogen Storage Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glycogen Storage Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting

Use of Continuous Glucose Monitoring to Evaluate Postprandial Response to Raw Cornstarch Supplementation in Adult Glycogen Storage Disease Type I

Glycogen Storage Disease Type I
Federico II University8 enrolled1 locationNCT07645898
Recruiting

Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease

Glycogen Storage Disease Type IaGlycogen Storage Disease Type IGlycogen Storage Disease Type IB+1 more
Connecticut Children's Medical Center10 enrolled1 locationNCT07459582
Recruiting

Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc140 enrolled19 locationsNCT06636383
Recruiting
Not Applicable

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

Glycogen Storage Disease Type I
Insel Gruppe AG, University Hospital Bern20 enrolled2 locationsNCT06852612
Recruiting

GBE Deficiency (GSD IV and APBD) Natural History Study

Glycogen Storage Disease Type IVAdult Polyglucosan Body DiseaseGSD4+2 more
Duke University200 enrolled1 locationNCT02683512
Recruiting

GSD VI and GSD IX Natural History

Glycogen Storage Disease VIGLYCOGEN STORAGE DISEASE IXa1GLYCOGEN STORAGE DISEASE IXa2+4 more
Duke University400 enrolled1 locationNCT04454216
Recruiting

Pompe Disease Registry Protocol

Pompe DiseaseGlycogen Storage Disease Type II
Genzyme, a Sanofi Company2,000 enrolled272 locationsNCT00231400
Recruiting

Pompe Pregnancy Sub-Registry

Pompe Disease (Late-onset)Glycogen Storage Disease Type II (GSD-II)Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company20 enrolled35 locationsNCT00567073
Recruiting
Phase 4

China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

Glycogen Storage Disease Type IIPompe's Disease
Genzyme, a Sanofi Company13 enrolled1 locationNCT06666413
Recruiting

Accuracy of Lactate Meter in GSDIa

Glycogen Storage Disease Type Ia
Connecticut Children's Medical Center10 enrolled1 locationNCT06843330
Recruiting
Phase 3

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Glycogen Storage Disease Type II Infantile Onset
Amicus Therapeutics36 enrolled14 locationsNCT04808505
Recruiting

Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques

Noonan SyndromeFabry DiseaseCardiac Amyloidosis+4 more
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07336394
Recruiting

Rare Glycogen Storage Diseases Natural History Study

Glycogen Storage DiseaseGSD Type 0AGSD Type 0B+12 more
Duke University200 enrolled1 locationNCT06795152
Recruiting
Phase 1Phase 2

A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

Glycogen Storage Disease Type Ia
Beam Therapeutics Inc.36 enrolled3 locationsNCT06735755
Recruiting
Not Applicable

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Myasthenia GravisHuntington DiseaseNeuromuscular Diseases+9 more
Centre Hospitalier Universitaire de Liege300 enrolled1 locationNCT07136844
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation

CardiomyopathiesHypertrophic Cardiomyopathy (HCM)Sudden Cardiac Death+14 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna700 enrolled3 locationsNCT06813443
Recruiting

French Observatory for Patients with Type 3 Glycogenosis

Glycogen Storage Disease Type III
Institut de Myologie, France150 enrolled3 locationsNCT06616545
Recruiting

'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'

Glycogen Storage Diseases
Institute of Liver and Biliary Sciences, India250 enrolled3 locationsNCT06396546
Recruiting

Natural History of Pompe Disease

Glycogen Storage Disease Type II, Adult
Assistance Publique - Hôpitaux de Paris20 enrolled1 locationNCT03564561